))
Putting Patients First: The Impact of Medical Affairs Featuring Linn Southall
Manage episode 383552350 series 3510932
Вміст надано Wesley Portegies and MedComms Experts. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Wesley Portegies and MedComms Experts або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Welcome to the Transforming Medical Communication podcast brought to you by MedComms Experts; I am your host, Wesley Portegies. This podcast explores the dynamic landscape of medical communication strategies, innovations, and challenges. We aim to facilitate insightful conversations that contribute to advancing effective medical communication practices.
Joining us today is Linn Southall, Medical Communications Director at Novartis Gene Therapies, for an insightful conversation on medical communications. Join us as Linn shares her valuable insights and experiences in the field, highlighting the importance of collaboration, personalized communication, and prioritizing patient outcomes. Tune in to discover how medical affairs and good business go hand in hand and gain a glimpse into the future of this ever-evolving industry.
Transforming Medical Communications is handcrafted by our friends over at: fame.so
Previous guests include: Sissy Easo-Joseph at GSK, Barbara Bish at Janssen, Drew Provan at Queen Mary University, Linn Southall at Novartis Gene Therapies
Check out our three most downloaded episodes:
Previous guests include: Sissy Easo-Joseph at GSK, Barbara Bish at Janssen, Drew Provan at Queen Mary University, Linn Southall at Novartis Gene Therapies
Check out our three most downloaded episodes:
- The Power of Integrated Medical Communications
- Enhancing Medical Affairs Training: Strategies and Innovations
- Putting Patients First: The Impact of Medical Affairs
10 епізодів
Поширити
